MAPK7 and neoplasm: In addition, our results strongly suggested that aberrant ERK5 signalling and NF-κB activation contributes to increased tumour cell proliferation, migration and metastasis, and that this pathway may be a potential novel, and extremely relevant therapeutic target in human CC.